FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Rare Pediatric Disease Priority Voucher Fee

[ Price : $8.95]

Federal Register notice: FDA announces the fee rate for using a rare pediatric disease priority review voucher for fiscal year 202...

Fee Rate for Medical Countermeasure Voucher

[ Price : $8.95]

Federal Register notice: FDA sets the fee rate for using a material threat medical countermeasure priority review voucher for fisc...

Drug, Biologicals Benefit/Risk Assessment Guidance

[ Price : $8.95]

FDA publishes a guidance on benefit/risk assessment in NDAs and BLAs.

3 Ex-FDA Lawyers Join Sidley

[ Price : $8.95]

Sidley says three former FDA attorneys have joined its Global Healthcare and FDA practice.

Use Data-Driven Approach to Drug Analysis: Researchers

[ Price : $8.95]

University of Chicago researchers say FDA should use a more data-driven approach to postmarket drug surveillance to avoid falsely ...

FDA Clears NeuroSENSE Monitor

[ Price : $8.95]

FDA clears NeuroWave Systems NeuroSENSE bilateral brain monitor to assess the adequacy of anesthesia and sedation in clinical sett...

Radiation Exposure with Disinfectant Wand

[ Price : $8.95]

FDA issues a warning about the potential risk of injury associated with the use of Max-Lux Corp.s Safe-T-Lite UV Wand because use...

FDA OKs Mirums Livmarli for Rare Liver Disease

[ Price : $8.95]

FDA approves Mirums Livmarli to treat cholestatic pruritus in patients with Alagille syndrome age one and older.

Magellan Diagnostics Recalls Blood Lead Tests

[ Price : $8.95]

Magellan Diagnostics recalls its LeadCare II, LeadCare Plus, and LeadCare Ultra blood lead tests due to concerns about false low r...

FDA Staff Update on Data Integrity Issues

[ Price : $8.95]

A panel of FDA staff from CDER and the Office of Regulatory Affairs provide the latest insights into common data integrity inspect...